Selcia has launched its new Fragment Screening Platform and unveiled their new brand as part of international expansion plans. Selcia have acquired the Intellectual Property and expertise of
Skinvisible has entered into an exclusive license agreement with Mayquest Pharmaceuticals for the rights for DermSafe, Skinvisible’s patented antimicrobial hand sanitizer lotion proven to kill the H1N1 swine
Hanford Pharmaceuticals has completed the sale of its Cephalosporin manufacturing facility in Syracuse, NY, on September 24, 2009. As part of the deal, Hanford will continue to manufacture
Actavis has launched the antiepileptic drug Topiramate in the UK, Germany, France and Switzerland. The product was launched on day one as the originator’s patent expired on 25
Precision BioSciences has announced that the US Patent and Trademark Office (USPTO) has granted Precision’s requests for inter partes reexamination of US Patent Nos 6610545 (the ‘545 patent)
Watson Pharmaceuticals has posted findings of a double-blind study which demonstrate that Gelnique was comparable to placebo in its effect on memory tests and other cognitive functions in
Icagen has initiated a proof-of-mechanism study of ICA-105665 for the treatment of pain. ICA-105665 is a novel, orally available opener of subtypes of KCNQ channels, to treat certain
Cell Therapeutics (CTI) has applied to the European Medicines Agency (EMEA) for orphan drug designation for pixantrone. CTI initiated the process of obtaining marketing approval in Europe in
MSD has presented a post-hoc analysis of data pooled from studies of 104 weeks in duration, which showed ‘Januvia’ (sitagliptin), when taken alone or in combination with metformin,
Repros Therapeutics has received further clarification from the Food and Drug Administration (FDA) on the Full Clinical Hold status of Proellex. As announced in early August 2009, and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.